AIFortune4 days ago
Abridge raises $1.1B with NVIDIA and Eli Lilly backing
4 min read
Abridge announced an AI-native clinician intelligence platform with investment from Eli Lilly and NVIDIA. The system documents patient-clinician conversations and supports billing, clinical decision support, payer adjudication, and trial screening. Over 300 health systems use the platform, supporting 100 million conversations annually.
Level
Hype check
Tap to vote and see what everyone thinks.
